156 related articles for article (PubMed ID: 21219355)
1. Plasma and tissue pharmacokinetics of danofloxacin in healthy and in experimentally infected chickens with Pasteurella multocida.
Zeng Z; Deng G; Shen X; Rizwan-Ul-Haq M; Zeng D; Ding H
J Vet Pharmacol Ther; 2011 Feb; 34(1):101-4. PubMed ID: 21219355
[No Abstract] [Full Text] [Related]
2. Comparative pharmacokinetics of danofloxacin in healthy and Pasteurella multocida infected ducks.
Xiao X; Lan W; Wang Y; Jiang L; Jiang Y; Wang Z
J Vet Pharmacol Ther; 2018 Dec; 41(6):912-918. PubMed ID: 30182430
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of florfenicol in healthy and Pasteurella multocida-infected Gaoyou ducks.
Lan W; Xiao X; Jiang Y; Jiang L; Zhao X; Yu Z; Zhu B; Li C; Bian L; Wang Z
J Vet Pharmacol Ther; 2019 May; 42(3):355-360. PubMed ID: 30912167
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of doxycycline against experimental Pasteurella multocida infection in broiler chickens.
Semjén G; Magyar T; Laczay P
Acta Vet Hung; 1998; 46(1):85-93. PubMed ID: 9704513
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of avian Escherichia coli and Pasteurella multocida to danofloxacin and five other antimicrobials.
Raemdonck DL; Tanner AC; Tolling ST; Michener SL
Avian Dis; 1992; 36(4):964-7. PubMed ID: 1336664
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics of orbifloxacin in healthy and Pasteurella multocida infected ducks.
Tohamy MA
Br Poult Sci; 2011 Oct; 52(5):639-44. PubMed ID: 22029792
[TBL] [Abstract][Full Text] [Related]
7. Influence of Pasteurella multocida infection on the pharmacokinetic behavior of marbofloxacin after intravenous and intramuscular administrations in rabbits.
Abo-el-Sooud K; Goudah A
J Vet Pharmacol Ther; 2010 Feb; 33(1):63-8. PubMed ID: 20444027
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Pasteurella multocida in a tissue-cage model in yellow cattle.
Shan Q; Wang J; Yang F; Ding H; Liang C; Lv Z; Li Z; Zeng Z
J Vet Pharmacol Ther; 2014 Jun; 37(3):222-30. PubMed ID: 24033339
[TBL] [Abstract][Full Text] [Related]
9. PCR assay for rapid detection of Pasteurella multocida serogroup A in morbid tissue materials from chickens with fowl cholera.
Shivachandra SB; Kumar AA; Gautam R; Singh VP; Chaudhuri P; Srivastava SK
Vet J; 2004 Nov; 168(3):349-52. PubMed ID: 15501155
[No Abstract] [Full Text] [Related]
10. Activity of fosfomycin against Pasteurella.
Frost BM; Valiant ME; Benson L; Dulaney EL
Avian Dis; 1974; 18(4):578-89. PubMed ID: 4139947
[No Abstract] [Full Text] [Related]
11. Effect of sulfachloropyrazine in the drinking water of chickens infected experimentally with fowl cholera.
Anderson NG; Alpaugh WC; Baughn CO
Avian Dis; 1974 Jul; 18(3):410-5. PubMed ID: 4851697
[No Abstract] [Full Text] [Related]
12. Pathogenicity and drug susceptibility of the Pasteurella anatis isolated in chickens in Taiwan.
Lin MY; Lin KJ; Lan YC; Liaw MF; Tung MC
Avian Dis; 2001; 45(3):655-8. PubMed ID: 11569739
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of fowl cholera diagnosed in Georgia, 1989-91.
Waltman WD; Horne AM
Avian Dis; 1993; 37(2):616-21. PubMed ID: 8363525
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth and alteration of host cell interactions of Pasteurella multocida with natural byproducts.
Salaheen S; Almario JA; Biswas D
Poult Sci; 2014 Jun; 93(6):1375-82. PubMed ID: 24879687
[TBL] [Abstract][Full Text] [Related]
15. Pasteurella multocida in scavenging family chickens and ducks: carrier status, age susceptibility and transmission between species.
Mbuthia PG; Njagi LW; Nyaga PN; Bebora LC; Minga U; Kamundia J; Olsen JE
Avian Pathol; 2008 Feb; 37(1):51-7. PubMed ID: 18202950
[TBL] [Abstract][Full Text] [Related]
16. Studies on Pasteurella multocida of birds. Third communication: Serological typing of Pasteurella multocida strains isolated from chickens and turkeys.
Farid AH; Torky HA; el-Nimr MM; Akeula M; Ezzat M
Arch Exp Veterinarmed; 1987 Mar; 41(2):202-7. PubMed ID: 3606315
[No Abstract] [Full Text] [Related]
17. Integrated pharmacokinetic-Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets.
Zeng QL; Mei X; Su J; Li XH; Xiong WG; Lu Y; Zeng ZL
BMC Vet Res; 2017 Jun; 13(1):178. PubMed ID: 28619095
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of florfenicol in normal and Pasteurella-infected Muscovy ducks.
el-Banna HA
Br Poult Sci; 1998 Sep; 39(4):492-6. PubMed ID: 9800032
[TBL] [Abstract][Full Text] [Related]
19. Study of the immunological response of chickens to P. multocida bacterins with and without adjuvant by immunoblotting.
Gunawardana GA; Frost AJ; Wilkie I
Br Poult Sci; 2004 Apr; 45 Suppl 1():S40-1. PubMed ID: 15222362
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model.
Qu Y; Qiu Z; Cao C; Lu Y; Sun M; Liang C; Zeng Z
BMC Vet Res; 2015 Dec; 11():294. PubMed ID: 26631082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
